Safety and Patient Considerations The FDA has highlighted risks with compounded Semaglutide, including dosing errors and adverse events, some requiring hospitalization (FDA Alerts on Dosing Errors)
If patients do not tolerate a dose during dose escalation, consider delaying dose escalation for 4 weeks The maintenance dosages of Wegovy for weight reduction in adults are 1.7 mg, 2.4 mg (recommended), or 7.2 mg (when additional weight reduction is clinically indicated) injected subcutaneously once weekly
Comparing Your Options When selecting a weight loss medication, understanding the differences is crucial
Writing down details can make the conversation easier and more productive
Wellness injections exist at a lower price tier
FDA Application Timeline and What to Expect in 2025 FDA review processes for weight-loss drugs involve scrutiny of safety, efficacy, and manufacturing controls